Vera Therapeutics, Inc. cotiza a 26.82 USD y tiene una capitalización bursátil de $1.9B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with immunological diseases. The company offers atacicept, a fully humanized TACI-Fc fusion protein that binds B-cell activating factor (BAFF) and A proliferation-i…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-1.52 | $-1.69 | $-1.39 |
| Estimado | $-1.61 | $-1.59 | $-1.37 | $-1.27 |
| Sorpresa | — | +4.4% | -23.4% | -9.4% |
| Métrica | VERA | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -49.6% | -40.4% | -9.2% |
| ROA | -40.8% | -32.0% | -8.8% |
| Current Ratio | 13.64 | 2.84 | +10.80 |
| Debt / Equity | 0.12 | 0.28 | -0.16 |